Vivos Therapeutics (VVOS) Other Working Capital Changes (2020 - 2026)
Vivos Therapeutics (VVOS) reported Other Working Capital Changes of $18000.0 for Q1 2026, up 104.51% year-over-year from $8801.5 in Q1 2025, and down 93.64% on a QoQ basis from $283000.0 in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Other Working Capital Changes data on file, last reported at $18000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 104.51% year-over-year to $18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $472000.0 (up 164.13% YoY) and the FY2025 annual result came in at $55000.0, down 67.07% from the prior year.
- Other Working Capital Changes declined to $18000.0 in Q1 2026 per VVOS's latest filing, from $283000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q4 2024 and bottomed at -$784000.0 in Q2 2024.
- The 5-year median for Other Working Capital Changes is -$130000.0 (2025), against an average of -$42235.3.
- Peak annual rise in Other Working Capital Changes reached 460.0% in 2024, while the deepest fall reached 1236.73% in 2024.
- Tracing VVOS's Other Working Capital Changes over 5 years: stood at -$667000.0 in 2022, then soared by 38.83% to -$408000.0 in 2023, then surged by 370.1% to $1.1 million in 2024, then sank by 74.32% to $283000.0 in 2025, then tumbled by 93.64% to $18000.0 in 2026.
- Per Business Quant, the three latest VVOS Other Working Capital Changes figures stand at $18000.0 (Q1 2026), $283000.0 (Q4 2025), and -$130000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | -440,000.00 |
| Dec 31, 2025 | -440,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Mar 31, 2025 | -399,000.00 |
| Mar 31, 2025 | -399,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | -566,000.00 |
| Jun 30, 2024 | -566,000.00 |
| Mar 31, 2024 | 504,000.00 |
| Mar 31, 2024 | 504,000.00 |
| Dec 31, 2023 | 570,000.00 |
| Dec 31, 2023 | 570,000.00 |
| Sep 30, 2023 | -264,000.00 |
| Sep 30, 2023 | -264,000.00 |
| Jun 30, 2023 | -390,000.00 |
| Jun 30, 2023 | -390,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Dec 31, 2022 | -308,000.00 |
| Dec 31, 2022 | -308,000.00 |
| Sep 30, 2022 | 184,000.00 |
| Sep 30, 2022 | 184,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Mar 31, 2022 | -240,000.00 |
| Mar 31, 2022 | -240,000.00 |
| Dec 31, 2021 | 352,000.00 |
| Dec 31, 2021 | 352,000.00 |
| Sep 30, 2021 | -803,000.00 |
| Sep 30, 2021 | -803,000.00 |
| Jun 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 1.14 Mn |
| Mar 31, 2021 | -136,000.00 |
| Mar 31, 2021 | -136,000.00 |
| Dec 31, 2020 | -140,736.00 |
| Dec 31, 2020 | -140,736.00 |
| Sep 30, 2020 | 249,525.00 |
| Sep 30, 2020 | 249,525.00 |
| Jun 30, 2020 | 4,603.00 |
| Jun 30, 2020 | 4,603.00 |
| Mar 31, 2020 | 608.00 |
| Mar 31, 2020 | 608.00 |